News Biogen teams up with gene-editing startup Scribe on ALS prog... Scribe Therapeutics, a start-up focusing on gene-editing using CRISPR/Cas9, has burst onto the biotech scene with a $415 million deal with Biogen.
Digital Reuters Pharma USA 2024 – Serena Goodwin AI is changing workflows for all kinds of pharma stakeholders, including sales representatives and medical affairs liaisons.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.